News 2024-09-19
Porton Showcases At CPhI Europe, Meeting Your CDMO Experts In Booth 5C17
CPhI Europe stands as a worldwide event in the pharmaceutical industry, bringing together key players, thought leaders, and businesses from across the globe. The event serves as an unparalleled platform for powerful networking, fostering collaborations, and driving forward the growth and innovation of the pharmaceutical sector.
As one of the world's leading CDMO companies, Porton Pharma Solutions will be attending the event. We will engage face-to-face with industry elites from around the world to gain deep insights into the latest trends and developments in the pharmaceutical industry. Additionally, we will share our extensive industry knowledge and product development experience, jointly exploring product innovation to drive forward industry innovation and high-quality growth.
To better interact with industry peers, we have specially arranged two professional presentation sessions at booth 5C17 on the second day (October 9). Our two technical experts will provide cutting-edge technical insights and industry perspectives. The detailed schedule is as follow:
This event will comprehensively showcase Porton's latest achievements in globalization, technological development, and innovation, providing you with fresh perspectives and new ideas to help you gain a competitive edge in the fierce market. If you are interested in attending our booth activities at CPhI, please plan your schedule in advance to join us for discussions. We sincerely invite you to visit us, to explore industry trends together, and to collectively promote high-quality development in the pharmaceutical industry.
From new drug development and process transfer optimization to commercial manufacturing, Porton is dedicated to attentively listening to customer needs and delivering efficient, precise CDMO solutions. Our expertise spans from small molecules (DS-DP) to tides, biologics, and conjugates. For onsite meeting appointments, please contact business@portonpharma.com.
We look forward to seeing you in Milan and witnessing the bright future of the pharmaceutical industry together!
Others
MoreNews 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.